Table 2.
Any grade | Grades 1–2 | Grade 3 | |
---|---|---|---|
Any adverse event | 135 | 120 | 15 |
Any treatment-related adverse event | 31 | 28 | 3 |
Specific treatment-related adverse event (immune) | |||
Anaphylaxis (with hypotension and angioedema) | 1 | 0 | 1 |
Arthralgia (flare of rheumatoid arthritis) | 1 | 1 | 0 |
Colitis* | 2 | 1 | 1 |
Pruritus | 7 | 7 | 0 |
Rash | 4 | 4 | 0 |
Uveitis | 1 | 1 | 0 |
Specific treatment-related adverse event (nonimmune) | |||
Abdominal Pain | 1 | 1 | 0 |
Anorexia | 2 | 2 | 0 |
Chills | 1 | 1 | 0 |
Dermatitis (radiation) | 1 | 1 | 0 |
Diaphoresis | 1 | 1 | 0 |
Diarrhea* | 1 | 1 | 0 |
Fatigue | 3 | 2 | 1 |
Headache | 1 | 1 | 0 |
Nausea | 4 | 4 | 0 |
Non-treatment related adverse events | 104 | 92 | 12 |
There were no grade 4 toxicities.
* Diarrhea was defined as a disorder characterized by frequent and watery bowel movements; colitis was defined as a disorder characterized by inflammation of the colon.